Director Mary Lynne Hedley filed a Form 4 with the SEC on November 17, 2026, disclosing an acquisition of Eli Lilly common stock on November 16, 2026.

Key Highlights

  • Reporting person: Mary Lynne Hedley, identified as a Director of Eli Lilly & Co (NYSE:LLY).
  • Shares acquired: 167.6364 shares of common stock acquired on November 16, 2026, coded as transaction type "A" (acquired).
  • Price per share: $1,431.67, as reported in the filing.
  • Direct holdings following transaction: 2,429.9017 shares of common stock held directly after the reported transaction.
  • Indirect holdings: 98 shares of common stock held indirectly by trust, with a disclaimer of beneficial ownership beyond pecuniary interest.
  • Signed by: Jonathan Groff on behalf of Mary Lynne Hedley, pursuant to an authorization on file, dated November 17, 2026.

Mary Lynne Hedley's November 2026 Common Stock Acquisition at Eli Lilly

According to the Form 4 filing submitted to the SEC on November 17, 2026, Mary Lynne Hedley, a Director of Eli Lilly & Co (NYSE:LLY), acquired 167.6364 shares of common stock on November 16, 2026, at a price of $1,431.67 per share. The transaction is coded "A," indicating an acquisition. Following the transaction, the filing reports that Hedley directly beneficially owns 2,429.9017 shares of Eli Lilly common stock.

In addition to the directly held shares, the filing discloses 98 shares of common stock held indirectly by trust. The filing includes a footnote stating that "the reporting person disclaims beneficial ownership of the reported securities except to the extent of the reporting person's pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."

No derivative securities transactions were reported in Table II of the filing. The form was signed by Jonathan Groff for Mary Lynne Hedley, pursuant to an authorization on file, on November 17, 2026. No amendment date is listed, indicating this is not an amended filing.

What Was Disclosed

The filing reports that Director Mary Lynne Hedley acquired 167.6364 shares of Eli Lilly common stock on November 16, 2026, at $1,431.67 per share, bringing her direct holdings to 2,429.9017 shares, with an additional 98 shares held indirectly by trust.